Postremission therapy in older adults with acute myeloid leukemia: an opportunity for new drug development
Author:
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Link
http://www.nature.com/articles/2402487.pdf
Reference6 articles.
1. Schiffer CA, Dodge R, Larson RA . Long-term follow-up of Cancer And Leukemia Group B studies in acute myeloid leukemia Cancer 1997 80 (11 Suppl.): 2210–2214
2. Lee EJ, George ST, Caligiuri M, Szatrowski TP, Powell BL, Lemke S, Didge RK, Smith R, Baer M, Schiffer CA . Parallel phase I studies of daunorubicin given with cytosine arabinoside and etoposide with or without the multidrug resistance modulator PSC-833 in previously untreated patients ⩾60 years of age with acute myeloid leukemia: results of Cancer and Leukemia Group B study 9420 J Clin Oncol 1999 17: 2831–2839
3. Schiffer CA . Acute myeloid leukemia in adults: where do we go from here? Cancer Chemother Pharmacol 2001 48 (Suppl. 1): S45–S52
4. Mayer RJ, Davis RB, Schiffer CA, Berg DT, Powell BL, Schulman P, Omura GA, Moore JO, Mcintyre OR, Frei E for the Cancer and Leukemia Group B. Intensive postremission chemotherapy in adults with acute myeloid leukemia N Engl J Med 1994 331: 896–903
5. Stone RM, Berg DT, George SL et al. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine Blood 2001 98: 548–553
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dasatinib Accelerates Valproic Acid-Induced Acute Myeloid Leukemia Cell Death by Regulation of Differentiation Capacity;PLoS ONE;2014-06-11
2. Treatment decisions for elderly patients with haematological malignancies: a dilemma;The Lancet Oncology;2012-08
3. Comparison of Reduced-Intensity Hematopoietic Cell Transplantation with Chemotherapy in Patients Age 60-70 Years with Acute Myelogenous Leukemia in First Remission;Biology of Blood and Marrow Transplantation;2011-12
4. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461;Blood;2006-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3